Date | Open | Close | Daily High | Daily Low |
---|
Date | Analyst | Rating | Price | |||
---|---|---|---|---|---|---|
04/28/25 | Keefe, Bruyette & Woods, Inc. | Maintained Buy | $366 | |||
04/11/25 | Barclays Capital | Maintained Sell | $316 | |||
04/11/25 | Jefferies & Company Inc. | Maintained Buy | $371 | |||
04/09/25 | Keefe, Bruyette & Woods, Inc. | Maintained Buy | ||||
03/18/25 | UBS | Upgraded to Buy | $395 | |||
07/26/24 | Wells Fargo & Co | Maintained Buy | $321 | |||
07/10/24 | Morgan Stanley | Maintained Hold | $272 | |||
06/20/24 | Wells Fargo & Co | Maintained Buy | $318 | |||
05/22/24 | Bank of America Merrill Lynch | Upgraded to Hold | $304 | |||
05/06/24 | Keefe, Bruyette & Woods, Inc. | Maintained Buy | $311 | |||
04/29/24 | Citigroup Corp. | Maintained Buy | $312 | |||
04/26/24 | Evercore | Maintained Hold | $295 | |||
04/26/24 | Piper Sandler | Maintained Buy | $303 | |||
04/11/24 | Wells Fargo & Co | Maintained Buy | $318 | |||
04/10/24 | Keefe, Bruyette & Woods, Inc. | Maintained Buy | $317 | |||
03/28/24 | Raymond James Financial, Inc. | Maintained Buy | $315 | |||
02/12/24 | Citigroup Corp. | Upgraded to Buy | $315 | |||
02/12/24 | BMO Capital Markets | Upgraded to Buy | $298 | |||
02/07/24 | Morgan Stanley | Maintained Hold | $270 | |||
02/07/24 | Wells Fargo & Co | Maintained Buy | $320 | |||
02/07/24 | Stifel, Nicolaus & Co., Inc. | Maintained Buy | $268 | |||
01/11/24 | Wells Fargo & Co | Upgraded to Buy | $288 | |||
10/31/23 | Raymond James Financial, Inc. | Maintained Buy | $255 | |||
10/27/23 | Piper Sandler | Maintained Buy | $267 | |||
10/27/23 | Morgan Stanley | Maintained Hold | $236 | |||
10/11/23 | Morgan Stanley | Maintained Hold | $225 | |||
10/06/23 | Jefferies & Company Inc. | Maintained Hold | $226 | |||
09/19/23 | Citigroup Corp. | Maintained Hold | $223 | |||
09/13/23 | Piper Sandler | Maintained Buy | $265 | |||
08/09/23 | Citigroup Corp. | Maintained Hold | $221 | |||
08/08/23 | BMO Capital Markets | Downgraded to Sell | $205 | |||
07/31/23 | Raymond James Financial, Inc. | Maintained Buy | $250 | |||
07/27/23 | Raymond James Financial, Inc. | Downgraded to Buy | $260 | |||
07/17/23 | Wells Fargo & Co | Maintained Hold | $243 | |||
06/20/23 | Morgan Stanley | Maintained Hold | $251 |
2025 | 2026 | 2027 | |
---|---|---|---|
Revenue | 9,580 | 10,123 | 10,761 |
Dividend | 3.64 | 3.79 | 3.97 |
Dividend Yield (in %) | 1.18 % | 1.22 % | 1.28 % |
EPS | 16.65 | 19.00 | 21.65 |
P/E Ratio | 18.57 | 16.27 | 14.29 |
EBIT | 2,394 | 2,584 | 2,847 |
EBITDA | 2,628 | 2,840 | 3,104 |
Net Profit | 1,650 | 1,820 | 2,028 |
Net Profit Adjusted | 1,650 | 1,820 | 2,028 |
Pre-Tax Profit | 2,115 | 2,359 | 2,671 |
Pre-Tax Profit Reported | 1,871 | 2,141 | 2,313 |
EPS (Non-GAAP) ex. SOE | 16.65 | 19.00 | 21.65 |
EPS (GAAP) | 15.19 | 17.71 | 20.19 |
Gross Income | - | - | - |
Cash Flow from Investing | - | - | - |
Cash Flow from Operations | 1,855 | 2,194 | 2,362 |
Cash Flow from Financing | - | - | - |
Cash Flow per Share | 21.13 | 23.71 | 26.10 |
Free Cash Flow | 1,586 | 1,856 | 2,011 |
Free Cash Flow per Share | - | - | - |
Book Value per Share | 84.58 | 88.44 | 94.68 |
Net Debt | 3,272 | 3,284 | 3,152 |
Research & Development Exp. | - | - | - |
Capital Expenditure | 182 | 186 | 195 |
Selling, General & Admin. Exp. | - | - | - |
Shareholder’s Equity | 8,284 | 8,604 | 9,102 |
Total Assets | 28,875 | 29,025 | 29,610 |
Previous Quarter ending 03/31/25 |
Current Quarter ending 06/30/25 |
Next Quarter ending 09/30/25 |
Current Year ending 12/31/25 |
Next Year ending 12/31/26 |
|
---|---|---|---|---|---|
Earnings Estimates | |||||
No. of Analysts | - | 18 | 17 | 19 | 19 |
Average Estimate | - | 2.638 USD | 3.004 USD | 16.652 USD | 19.003 USD |
Year Ago | - | 1.369 USD | -16.422 USD | -0.961 USD | - |
Publish Date | - | 7/24/2025 | 10/23/2025 | - | - |
Revenue Estimates | |||||
No. of Analysts | - | 12 | 12 | 14 | 14 |
Average Estimate | - | 2,234 USD | 2,273 USD | 9,580 USD | 10,123 USD |
Year Ago | - | 2,266 USD | 2,289 USD | 9,932 USD | - |
Publish Date | - | 7/24/2025 | 10/23/2025 | - | - |
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|---|---|
Sales | 9,932.00 | 9,481.00 | 8,862.00 | 9,004.00 | 9,348.00 | 9,035.00 | 8,485.00 |
Change of sales in % | 4.76 | 6.98 | -1.58 | -3.68 | 3.46 | 6.48 | 4.12 |
Gross profit on sales | 7,643.00 | 7,161.00 | 6,519.00 | 6,681.00 | 6,820.00 | 6,587.00 | 6,106.00 |
Gross profit on sales change in % | 6.73 | 9.85 | -2.42 | -2.04 | 3.54 | 7.88 | 4.72 |
Operating income | 2,123.00 | 1,830.00 | 1,311.00 | 1,422.00 | 1,314.00 | 1,360.00 | 982.00 |
Operating income change in % | 16.01 | 39.59 | -7.81 | 8.22 | -3.38 | 38.49 | -10.40 |
Income before tax | 104.00 | 1,279.00 | 1,258.00 | 2,692.00 | 1,338.00 | 1,322.00 | 851.00 |
Income before tax change in % | -91.87 | 1.67 | -53.27 | 101.20 | 1.21 | 55.35 | 74.03 |
Income after tax | -98.00 | 1,055.00 | 1,049.00 | 2,142.00 | 996.00 | 1,044.00 | 695.00 |
Income after tax change in % | - | 0.57 | -51.03 | 115.06 | -4.60 | 50.22 | 22.36 |
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|---|---|
Total liabilities | 19,664.00 | 19,497.00 | 21,676.00 | 21,662.00 | 27,599.00 | 25,057.00 | 22,388.00 |
Long-term liabilities per share | - | - | - | - | - | - | - |
Equity | 8,017.00 | 9,593.00 | 10,093.00 | 13,308.00 | 10,932.00 | 10,369.00 | 9,997.00 |
Equity change in % | -16.60 | -4.95 | -24.46 | 22.55 | 5.57 | 4.03 | -2.71 |
Balance sheet total | 27,681.00 | 29,090.00 | 31,769.00 | 34,970.00 | 38,531.00 | 35,426.00 | 32,385.00 |
Balance sheet total change in % | -4.84 | -8.43 | -9.15 | -9.24 | 8.76 | 9.39 | -0.22 |
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|---|---|
Sales per share | 97.37 | 89.44 | 79.13 | 69.80 | 71.91 | 69.50 | 64.28 |
P/E ratio (year end quote, basic EPS) | - | 24.23 | 25.62 | 15.94 | 27.50 | 25.15 | 28.84 |
P/E ratio (year end quote, diluted EPS) | - | 24.23 | 25.62 | 15.94 | 27.50 | 25.15 | 28.84 |
Dividend yield in % | 1.12 | 1.39 | 1.34 | 1.27 | 1.31 | 1.29 | 1.58 |
Equity ratio in % | 28.96 | 32.98 | 31.77 | 38.06 | 28.37 | 29.27 | 30.87 |
Debt ratio in % | 71.04 | 67.02 | 68.23 | 61.94 | 71.63 | 70.73 | 69.13 |
Name | Date | shares traded | shares held | Price | type (sell/buy) | option |
---|---|---|---|---|---|---|
Krasner Andrew Jay | 06/02/2025 | 1,600.00 | 11,982.33 | 315.75 | Sell | No |
REILLY PAUL C | 05/14/2025 | 412.00 | 1,291.00 | 303.37 | Sell | No |
Hunt Jacqueline | 05/14/2025 | 412.00 | 978.00 | 303.37 | Sell | No |
Tomczyk Fredric J | 05/14/2025 | 412.00 | 978.00 | 303.37 | Sell | No |
Swanback Michelle R | 05/14/2025 | 412.00 | 1,554.00 | 303.37 | Sell | No |
THOMAS PAUL D | 05/14/2025 | 600.00 | 13,043.00 | 303.37 | Sell | No |
REILLY PAUL C | 05/14/2025 | 1,032.23 | 2,323.23 | n/a | Buy | No |
Hunt Jacqueline | 05/14/2025 | 709.66 | 1,687.66 | n/a | Buy | No |
Tomczyk Fredric J | 05/14/2025 | 709.66 | 1,687.66 | n/a | Buy | No |
Swanback Michelle R | 05/14/2025 | 709.66 | 2,263.66 | n/a | Buy | No |
Hess Carl Aaron | 05/07/2025 | 6,062.00 | 89,583.52 | 308.78 | Sell | No |
Hess Carl Aaron | 05/07/2025 | 146.00 | 95,837.52 | 306.85 | Sell | No |
Hess Carl Aaron | 05/07/2025 | 709.00 | 85,983.52 | 310.74 | Sell | No |
Hess Carl Aaron | 05/07/2025 | 2,891.00 | 86,692.52 | 309.67 | Sell | No |
Hess Carl Aaron | 05/07/2025 | 192.00 | 95,645.52 | 307.91 | Sell | No |
Faber Alexis | 05/07/2025 | 265.00 | 7,980.97 | 306.92 | Sell | No |
Faber Alexis | 04/20/2025 | 4.00 | 8,245.97 | 337.95 | Sell | No |
Qureshi Imran Ahmed | 04/20/2025 | 7.00 | 7,900.34 | 337.95 | Sell | No |
Kurpis Joseph Stephen | 04/20/2025 | 1.00 | 1,203.80 | 337.95 | Sell | No |
Banas Kristy D | 04/20/2025 | 4.00 | 8,407.10 | 337.95 | Sell | No |
Furman Matthew | 04/20/2025 | 7.00 | 35,362.57 | 337.95 | Sell | No |
Krasner Andrew Jay | 04/20/2025 | 12.00 | 4,006.91 | 337.95 | Sell | No |
Pullum Anne | 04/20/2025 | 9.00 | 17,755.15 | 337.95 | Sell | No |
Gebauer Julie Jarecke | 04/20/2025 | 10.00 | 71,636.41 | 337.95 | Sell | No |
Thomson-Hall Pamela | 04/20/2025 | 2.00 | 5,831.23 | 337.95 | Sell | No |
Date | Name | Dividend | *yield | Currency |
---|---|---|---|---|
2024 | Willis Towers Watson PLC | 3.52 | 1.12 | USD |
2023 | Willis Towers Watson PLC | 3.36 | 1.39 | USD |
2022 | Willis Towers Watson PLC | 3.28 | 1.34 | USD |
2021 | Willis Towers Watson PLC | 3.02 | 1.27 | USD |
2020 | Willis Towers Watson PLC | 2.75 | 1.31 | USD |
2019 | Willis Towers Watson PLC | 2.60 | 1.29 | USD |
2018 | Willis Towers Watson PLC | 2.40 | 1.58 | USD |
2017 | Willis Towers Watson PLC | 2.12 | 1.41 | USD |
2016 | Willis Towers Watson PLC | 1.92 | 1.57 | USD |
2015 | Willis Towers Watson PLC | 3.28 | 2.55 | USD |
2014 | Willis Towers Watson PLC | 3.18 | 2.68 | USD |
2013 | Willis Towers Watson PLC | 2.97 | 2.50 | USD |
2012 | Willis Towers Watson PLC | 2.86 | 3.22 | USD |
2011 | Willis Towers Watson PLC | 2.75 | 2.68 | USD |
2010 | Willis Towers Watson PLC | 2.75 | 3.00 | USD |
2009 | Willis Towers Watson PLC | 2.75 | 3.94 | USD |
Event | Estimate | Info | Date |
---|---|---|---|
Earnings Report | 2.638 USD | Q2 2025 Earnings Release | 07/24/2025 |
Earnings Report | 3.004 USD | Q3 2025 Earnings Release | 10/23/2025 |
Earnings Report | 7.899 USD | Q4 2025 Earnings Release | 02/10/2026 |
Earnings Report | 3.628 USD | Q1 2026 Earnings Release | 04/23/2026 |
Event | Actual EPS | Info | Date |
---|---|---|---|
Earnings Report | 2.330 USD | Q1 2025 Earnings Release | 04/24/2025 |
Earnings Report | 12.250 USD | Q4 2024 Earnings Release | 02/04/2025 |
Earnings Report | -16.440 USD | Q3 2024 Earnings Release | 10/31/2024 |
Earnings Report | 1.360 USD | Q2 2024 Earnings Release | 07/25/2024 |
Annual General Meeting | 9.950 USD | Annual General Meeting | 05/22/2024 |
Earnings Report | 1.830 USD | Q1 2024 Earnings Release | 04/25/2024 |
Earnings Report | 5.970 USD | Q4 2023 Earnings Release | 02/06/2024 |
Earnings Report | 1.290 USD | Q3 2023 Earnings Release | 10/26/2023 |
Earnings Report | 0.880 USD | Q2 2023 Earnings Release | 07/27/2023 |
Annual General Meeting | 8.980 USD | Annual General Meeting | 05/17/2023 |
Earnings Report | 1.880 USD | Q1 2023 Earnings Release | 04/27/2023 |
Earnings Report | 5.400 USD | Q4 2022 Earnings Release | 02/09/2023 |
Earnings Report | 1.720 USD | Q3 2022 Earnings Release | 10/27/2022 |
Earnings Report | 0.970 USD | Q2 2022 Earnings Release | 07/28/2022 |
Annual General Meeting | 32.780 USD | Annual General Meeting | 06/08/2022 |
Earnings Report | 1.030 USD | Q1 2022 Earnings Release | 04/28/2022 |
Earnings Report | 19.190 USD | Q4 2021 Earnings Release | 02/08/2022 |
Name | Job |
---|---|
Adam Laird Garrard | Chairman-Risk & Broking |
Joseph S. Kurpis | Chief Accounting Officer & Controller |
Andrew Krasner | Chief Financial Officer |
Kristy Banas | Chief HR Officer, Head-Marketing & Communication |
Alexis Faber | Chief Operating Officer |
Brad Messinger | Client Relationship Director |
Debra Woida | Dir & Head-Delegated Investment Services, NA |
Matthew Gooden | Director & Head-Sales, Professional Indemnity Team |
Nick Dussuyer | Director-Sales & Client Management Europe |
Patricia Pang | Executive Director-Financial Solutions |
Matthew S. Furman | General Counsel |
Cassie Waller | Global Head-Intermediaries & Asset Management |
Eric Latalladi | Global Head-Technology |
Ed Louth | Head-Airline Broking |
Gene Harry Wickes | Head-Benefits Delivery & Administration |
Ben Dunston | Head-Broking, Asia |
Anne Pullum | Head-Corporate Risk & Broking Europe |
Alberto Gallego | Head-Corporate Risk & Broking-Western Europe |
Nicolas Aubert | Head-Great Britain |
Kirsten Beasley | Head-Health Care Broking, Corp Risk & Broking, NA |
Pamela Jane Thomson-Hall | Head-International |
Taro Ogai | Head-Investments, Asia-Pacific |
Claudia de la Hoz | Head-Investor Relations |
Evelyn Schilter | Head-Legal Retirement |
Katherine Gehman | Head-Marketing |
Joseph T. Gunn | Head-North America |
Mark Hiles | Head-Pwr, Utilities-Central & Eastern EMEA Region |
Patrick Donnelly | Head-Risk & Broking |
Stephen Mark Chipman | Independent Director |
Fredric John Tomczyk | Independent Director |
Fumbi Chima | Independent Director |
Inga Kristine Beale | Independent Director |
Michael Hammond | Independent Director |
Michelle Swanback | Independent Director |
Jacqueline Hunt | Independent Director |
Nick Horsfall | MD-Client Business Dev Team-Asset Mgmt Exchange |
Paul C. Reilly | Non-Executive Chairman |
Carl Aaron Hess | President, Chief Executive Officer & Director |
Julie Jarecke Gebauer | President-Health, Wealth & Career |
Lucy Clarke | President-Risk & Broking |
Rosemarie Chen | Principal |
Nicole Napolitano | Secretary & General Counsel |
Kartina Tahir Thomson | Senior Director |
Vincent Kane | Senior Director-Health & Group Benefits |